Best Solution in the Digital Therapy - 4th Digital Summit Award
2023-12-08
Last week, we had the pleasure of presenting Cytocast's cutting-edge technology at the 4th Digital Health Summit as the Best Solution in the Digital Therapy category winner.
Imagine...a world where new therapies can be discovered and developed in a fraction of what it takes now.
a world where new therapies can be discovered and developed in a fraction of what it takes now.
How can we help?
Drug Discovery
Precision medicine
People and Values
Cytocast is an emerging TechBio startup based in Budapest that specializes in data-driven medical technology. We leverage this data to add value and achieve impactful results.
OUR VALUES
We are proud to be a company with a curious mindset and a strong research orientation. What sets us apart is the way we integrate multi-omics data, extensive scientific knowledge, expertise, high-performance computing, and cutting-edge data science methods to maximize insights into patient biology and accelerate the pace of drug discovery and development. We also have the privilege of working with numerous collaborative partners. We value these partnerships and recognize their importance in advancing our mission.
MAKE MEDICINE BETTER WITH ADVANCED CELL SIMULATION TECHNOLOGY
THE TEAM
At Cytocast, we believe in creative solutions and in the power of teamwork in a familiar atmosphere. Many of our team members have university affiliations continually exploring new possibilities.
How we do it
Cytocast is using computer simulations to determine the most effective treatment for patients while minimazing potential side effects
0
Proteins per simulation
0
Protein-protein interactions
0
Binding sites per simulation
0
Nr. of cell types
News
Cytocast Secures 1.65M Euros in Second Investment Round to Accelerate Innovation and Growth
2023-08-01
We are thrilled to announce that we have successfully secured our second investment round...
Cytocast at the Hungarian Molecular Life Science Conference
2023-03-27
Cytocast team recently participated in the Hungarian Molecular Life Science Conference held in Eger. The conference...
Blog
Virtual pathways to cures: the future of cellular modeling in pharmaceuticals
Cytocast’s dedication to science-driven solutions reflects a significant shift in the healthcare landscape, where computational modeling and simulations are becoming indispensable tools in the quest for faster, safer, and more effective medical treatments
The Role of Digital Twins in revolutionizing drug discovery
The process of narrowing down viable drug candidates can take years, costing millions along the way. With the Cytocast Digital Twin Patient, however, researchers can now conduct these trials in silico in a fraction of the time.
Cytocast Q2-Q3 2024: Innovations in digital twin technology, simulations and predictions
2024-10-04
Cytocast has made significant strides during the second quarter of 2024, advancing its cutting-edge technology in the field of digital twin simulations and predictive algorithms.
Interested in a demo?
Get in touch today to see how the Cytocast Digital Twin™ platform works.
Contact us